Bio-imaging: late gadolinium enhancement in hypertrophic cardiomyopathy and its relation to novel biomarkers of fibrosis

Bio-imaging: late gadolinium enhancement in hypertrophic cardiomyopathy and its relation to novel biomarkers of fibrosis

Bibliographic Details
Main Authors:	Abdel-Aty Hassan, Katus Hugo A, Steen Henning, Lehrke Stephanie
Format:	Article
Language:	English
Published:	BMC 2012-02-01
Series:	Journal of Cardiovascular Magnetic Resonance

Similar Items

CMR derived MAPSE and TAPSE Measurements in hypertrophic cardiomyopathy: comparison to healthy volunteers
by: Abdel-Aty Hassan, et al.
Published: (2012-02-01)

Myocardial bridging in patients with hypertrophic cardiomyopathy is not associated with late gadolinium enhancement at cardiac magnetic resonance imaging
by: Hees Tilman A, et al.
Published: (2013-01-01)

Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy
by: Di Bella Gianluca, et al.
Published: (2010-04-01)

Clinical significance of late gadolinium enhancement in pediatric patients with hypertrophic cardiomyopathy
by: Smith Brandon M, et al.
Published: (2013-01-01)

Ventricular arrhythmias in apical hypertrophic cardiomyopathy: association with late gadolinium enhancement
by: Lopes Mário G, et al.
Published: (2010-01-01)

Arrhythmogenic risk of late gadolinium enhancement in patients with hypertrophic cardiomyopathy: Burden and location?
by: Mahdi Montazeri, et al.
Published: (2020-11-01)

Arrhythmogenic risk of late gadolinium enhancement in patients with hypertrophic cardiomyopathy: Burden and location?
by: Mahdi Montazeri, et al.
Published: (2020-11-01)

Late gadolinium enhancement as an independent predictor of atrial fibrillation in hypertrophic cardiomyopathy (HCM)
by: Dawson Dana, et al.
Published: (2009-01-01)

Phenotypic expression in hypertrophic cardiomyopathy and late gadolinium enhancement on cardiac magnetic resonance
by: Francisca Caetano, et al.
Published: (2014-05-01)

The Association between the Extent of Late Gadolinium Enhancement and Diastolic Dysfunction in Hypertrophic Cardiomyopathy
by: Deniz Alis, et al.
Published: (2021-04-01)

Detection and prevalence of myocardial infarction early and late after heart transplantation detected by late gadolinium enhanced MRI
by: Steen Henning, et al.
Published: (2012-02-01)

Late gadolinium enhancement location assessed by magnetic resonance and arrhythmogenic risk in hypertrophic cardiomyopathy
by: Ana Raquel Barbosa, et al.
Published: (2020-11-01)

Late gadolinium enhancement location assessed by magnetic resonance and arrhythmogenic risk in hypertrophic cardiomyopathy
by: Ana Raquel Barbosa, et al.
Published: (2020-11-01)

Late gadolinium enhancement cardiovascular magnetic resonance in genotyped hypertrophic cardiomyopathy with normal phenotype
by: Jassal Davinder S, et al.
Published: (2008-12-01)

Non-invasive measurement of myocardial extracellular volume using T1 mapping as a novel biomarker of diffuse fibrosis in dilated cardiomyopathy
by: aus dem Siepen Fabian, et al.
Published: (2013-01-01)

Myocardial late gadolinium enhancement cardiovascular magnetic resonance in patients with cirrhosis
by: Stremmel Wolfgang, et al.
Published: (2010-08-01)

Diagnostic questions in hypertrophic cardiomyopathy: What is the significance of late gadolinium enhancement on cardiac magnetic resonance?
by: Ana G. Almeida
Published: (2014-05-01)

Relationship between Extension or Texture Features of Late Gadolinium Enhancement and Ventricular Tachyarrhythmias in Hypertrophic Cardiomyopathy
by: Yasuo Amano, et al.
Published: (2018-01-01)

A Rare Case of Hypertrophic Cardiomyopathy with Subendocardial Late Gadolinium Enhancement in an Apical Aneurysm with Thrombus
by: Yusuke Morita, et al.
Published: (2014-01-01)

Comparison of Gadopentetate dimeglumine and Gadobenate dimeglumine in depiction of non-ischemic fibrosis in hypertrophic cardiomyopathy
by: Schulz-Menger Jeanette, et al.
Published: (2009-01-01)

2049 Improved detection of myocardial fibrosis using high-resolution, late gadolinium-enhanced cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy
by: Gibson C Michael, et al.
Published: (2008-10-01)

Reproducibility of Gadolinium Enhancement Patterns and Wall Thickness in Hypertrophic Cardiomyopathy
by: Gaston A. Rodriguez-Granillo, et al.
Published: (2016-01-01)

Adverse events in families with hypertrophic or dilated cardiomyopathy and mutations in the <it>MYBPC3 </it>gene
by: Lehrke Stephanie, et al.
Published: (2008-10-01)

Late gadolinium enhancement cardiovascular magnetic resonance for sudden cardiac death risk stratification in hypertrophic cardiomyopathy
by: Ismail Tevfik F, et al.
Published: (2013-01-01)

High sensitivity of late gadolinium enhancement for predicting microscopic myocardial scarring in biopsied specimens in hypertrophic cardiomyopathy.
by: Tetsuo Konno, et al.
Published: (2014-01-01)

Extent of late gadolinium enhancement detected by cardiovascular magnetic resonance correlates with the inducibility of ventricular tachyarrhythmia in hypertrophic cardiomyopathy
by: Germans Tjeerd, et al.
Published: (2010-05-01)

Characteristics and clinical associations of late gadolinium enhanced cardiovascular magnetic tesonance in lamin A/C, cardiac troponin T and myosin binding protein C gene mutation related cardiomyopathies
by: Franke Jennifer, et al.
Published: (2013-01-01)

GEISIR: gadolinium exposure induced systemic inflammatory response in dialysis patients
by: Katus Hugo A, et al.
Published: (2009-01-01)

Incremental benefit of late gadolinium cardiac magnetic resonance imaging for risk stratification in patients with hypertrophic cardiomyopathy
by: Christina Doesch, et al.
Published: (2017-07-01)

Influence of presence and patterns of late gadolinium enhancement on left ventricular remodeling after heart transplantation
by: Braggion Santos Maria, et al.
Published: (2013-01-01)

Myocardial fibrosis in hypertrophic cardiomyopathy
by: Patel, Vimal
Published: (2018)

Non-contrast T1 mapping characterizes the myocardium beyond that achieved by late gadolinium enhancement in both hypertrophic and dilated cardiomyopathy
by: Dass Sairia, et al.
Published: (2012-02-01)

Global circumferential left ventricular strain impairment in hypertrophic cardiomyopathy: comparison to left ventricular hypertrophy and late gadolinium enhancement
by: Macron Laurent, et al.
Published: (2013-01-01)

The extent of late gadolinium enhancement can be assessed fast and reproducible using semi-quantitative method in patients with hypertrophic cardiomyopathy
by: Gommans Frank, et al.
Published: (2013-01-01)

Relationship Between Obstructive Sleep Apnea and Late Gadolinium Enhancement and Their Effect on Cardiac Arrhythmias in Patients with Hypertrophic Obstructive Cardiomyopathy
by: Wang S, et al.
Published: (2021-03-01)

The amount of late gadolinium enhancement outperforms current guideline-recommended criteria in the identification of patients with hypertrophic cardiomyopathy at risk of sudden cardiac death
by: Pedro Freitas, et al.
Published: (2019-08-01)

Late gadolinium enhancement (LGE) on Cardiac MR is a powerful predictor of death and “hard” events in patients with hypertrophic cardiomyopathy (HCM)
by: Bhatti Sabha, et al.
Published: (2012-02-01)

Could native T1 mapping replace late gadolinium enhancement in the assessment of myocardial fibrosis in patients with cardiomyopathy?
by: Hend G Elsafty, et al.
Published: (2021-09-01)

Diffuse myocardial fibrosis in early forms of dilated cardiomyopathy: insights from T1 mapping cardiovascular magnetic resonance
by: aus dem Siepen Fabian, et al.
Published: (2013-01-01)

Derangement of cardiac energy metabolism is acutely exacerbated during exercise in hypertrophic cardiomyopathy, independent of hypertrophy or late gadolinium burden
by: Dass Sairia, et al.
Published: (2012-02-01)